top of page
doctor-scientist-conducting-clinical-experiment-using-micropipette.jpg

Next-Generation

Microbiology at Your Lab

One test for pan-bacteria, pan-fungi, key viruses, and AMR genes — results in 24 hours.

NGS DNA (3).png

Direct-from-sample NGS

One Report

One workflow

One Cost

Features

Unbiased Detection Power

Unlike rigid panel tests that read a fixed list, sequencing identifies whatever is present — enabling detection of rare pathogens, mixed infections, and antimicrobial resistance genes in a single run.

Automated ID & Reporting

The Ω ID platform streamlines analysis and reporting, with complete operator training provided during onboarding.

Culture independent workflow

Sequencing does not depend on culture growth or predefined targets, allowing superior detection of VBNC organisms and mutated strains.

Reagent Rental Convenience

The reagent-rental model places the full setup at your site, bundled with monthly reagent supply and application/support services.

Fast Turnaround Time

For validated matrices, results are typically delivered within ~24 hours.

Challenges With Current Microbiology Diagnostic Tools

Culture-dependent workflows add days to diagnosis and delay timely, targeted therapy.

Rigid panels miss rare, emerging, and mixed infections.

Mutations often go undetected without panel redesign.

Fragmented workflows and weak LIS feedback slow decisions and raise costs.

Limited early AMR insight drives broad-spectrum use.

Longer hospital stays, prolonged drug exposure and lower clinical confidence.

Next-generation sequencing (NGS) based infectious disease test enabling pan-bacteria, pan-fungi, key viruses, and ARG detection

Direct-from-sample workflow (no culture) using real-time Oxford Nanopore sequencing to detect rare, mixed, and VBNC infections.

Clinician-ready, comprehensive report in ~24 hours with actionable AMR insights.

No rigid panels — a hypothesis-free test that detects pathogens and ARGs in a single run.

Enables targeted therapy and informed de-escalation, helping reduce hospital stay, antibiotic exposure, and overall cost.

Zero-CapEx reagent-rental model with a fixed monthly commitment.

Solution — infexn®-NGS

Frequently asked questions

Manufactured by
HA_Logo-01 (2).png
  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon

© Copyright 2021. IMMUNOSHOP All Rights Reserved. 

Mumbai/ Hyderabad

bottom of page